| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $7.6M | +45.1% | +82.6% |
| SG&A Expense | $5.6M | -5.2% | +242.7% |
| Operating Income | -$12.8M | -17.9% | -119.1% |
| Income Tax | $0 | — | — |
| Net Income | -$11.9M | -20.3% | -106.5% |
| EPS (Basic) | -$0.13 | -18.2% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $39.1M | +293.6% | +1575.9% |
| Current Assets | $78.5M | -11.6% | +1774.3% |
| Total Assets | $79.6M | -10.4% | +1718.5% |
| Current Liabilities | $6.7M | -23.9% | +36.5% |
| Total Liabilities | $6.7M | -23.9% | +36.5% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.3M | — | — |
| Capital Expenditures | $13K | — | — |
| Investing Cash Flow | $2.2M | — | — |
| Financing Cash Flow | -$102K | — | — |
| Free Cash Flow | -$20.3M | — | — |
| +80.0% |
| EPS (Diluted) | -$0.13 | -18.2% | +80.0% |
| $72.9M |
| -8.9% |
| — |